Table 5 Univariate and multiple logistic regression analyses for factors significantly associated with metabolic syndrome compared between genders among all patients included in this study
| Variables |
Characteristics Metabolic syndrome | Univariate analysis | Multiple regression analysis | |||
|---|---|---|---|---|---|---|
| Yes | No | OR | 95% CI | OR | 95% CI | |
| Female gender, n (%) | 55 (37.2%) | 93 (62.8%) | ||||
| Psoriatic arthritis, n (%) | 47 (85.5%) | 42 (45.2%)* | 7.42* | 3.13–17.57 | 3.48* | 1.14–10.60 |
| Age > 40, n (%) | 50 (90.9%) | 48 (51.6%)* | 9.96* | 3.62–27.41 | 2.44 | 0.95–12.48 |
| History of smoking, n (%) | 2 (3.6%) | 2 (2.2%) | 1.54 | 0.21–11.24 | N/A | N/A |
| BMI > 23 kg/m2, n (%) | 42 (76.4%) | 40 (43.0%)* | 4.5* | 2.12–9.58 | 3.74* | 1.31–10.60 |
| Disease duration > 10 years, n (%) | 12 (21.8%) | 27 (29.0%) | 0.68 | 0.31–1.49 | N/A | N/A |
| SynAnk, median (IQR) | 5 (7) | 0 (3)* | 1.15* | 1.06–1.25 | 1.18* | 1.05–1.32 |
| ASDAS-CRP > 2.1, n (%) | 15 (34.1%) | 36 (52.9%)** | 0.36* | 0.16–0.81 | 0.37 | 0.14–1.01 |
| Male gender, n (%) | 46 (26.9%) | 125 (73.1%) | ||||
| Psoriatic arthritis, n (%) | 25 (54.3%) | 52 (41.6%) | 1.83** | 0.91–3.68 | 0.96 | 0.43–2.17 |
| Age > 40, n (%) | 39 (84.8%) | 75 (60.0%)* | 3.47* | 1.43–8.45 | 2.91* | 1.07–7.93 |
| History of smoking, n (%) | 11 (23.9%) | 40 (32.0%) | 0.65 | 0.29–1.47 | N/A | N/A |
| BMI > 23 kg/m2, n (%) | 42 (91.3%) | 56 (45.5%)* | 13.27* | 4.45–39.56 | 11.42* | 3.75–34.79 |
| Disease duration > 10 years, n (%) | 23 (50.0%) | 55 (44.0%) | 1.27 | 0.65–2.51 | N/A | N/A |
| SynAnk, median (IQR) | 7.5 (11) | 4.0 (11)* | 1.05* | 1.01–1.10 | 1.02 | 0.97–1.08 |
| ASDAS-CRP > 2.1, n (%) | 13 (34.2%) | 43 (44.8%) | 0.73 | 0.33–1.61 | N/A | N/A |